Quantum-Si Inc

Quantum-Si Incorporated (Nasdaq: QSI) is a life sciences semiconductor company specializing in next-generation protein sequencing technology that completed its SPAC merger and began trading publicly in 2021. Operating within the genomics and proteomics instrumentation sector, Quantum-Si filed an 8-K current report with the SEC on May 17, 2024, under accession number 0001140361-24-026703, disclosing a material event in accordance with standard securities regulations. The company develops chip-based platforms designed to sequence proteins in real time, targeting both research and clinical applications. As an active post-merger public company, QSI continues to meet ongoing SEC reporting obligations. Sign up at SpacDesk for full filing history, deal analytics, and comprehensive coverage of QSI and hundreds of other SPAC transactions.